Retraction:  In vivo  and  in vitro  effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of  SFRP1  gene via Wnt/&#x03B2;-catenin signaling pathway

Ling-Yu Kong; Mei Xue; Qing-Cai Zhang; Chuan-Fu Su

doi:10.18632/oncotarget.28616

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway

PDF | How to cite

Oncotarget. 2024; 15:574-574. https://doi.org/10.18632/oncotarget.28616

Metrics: PDF 92 views | ?

Ling-Yu Kong¹, Mei Xue², Qing-Cai Zhang³ and Chuan-Fu Su¹

¹Department of Breast, Linyi Cancer Hospital, Linyi 276000, P.R. China
²Department of Pathology, Linyi Cancer Hospital, Linyi 276000, P.R. China
³Operating Theatre, Daqing Oilfield General Hospital, Daqing 163000, P.R. China

Published: August 14, 2024

Copyright: © 2024 Kong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: In Figure 7C, the second and sixth panels contain images duplicated from Figure 7 of [1]. This same figure also contains a partially duplicated panel from Figure 7C of a second paper, which has been retracted [2]. The journal requested clarification regarding these images from the authors. The authors have acknowledged that some images provided by a third-party lab may be unreliable, and thus the data is compromised. In light of these facts, the Editorial decision was made to retract this paper. All authors agreed with the decision. Linyi cancer hospital acknowledged the retraction of this paper.

REFERENCES

1. Wu F, Li J, Guo N, Wang XH, Liao YQ. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathway. Am J Cancer Res. 2017; 7:405–16. [PubMed].
2. Mao XW, Xiao JQ, Xu G, Li ZY, Wu HF, Li Y, Zheng YC, Zhang N. CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/β-catenin signaling pathway. Oncotarget. 2017; 8:77241–53. https://doi.org/10.18632/oncotarget.20455. [PubMed]. Retraction in: Oncotarget. 2024; 15:542–542. https://doi.org/10.18632/oncotarget.28407. [PubMed].

Original article: Oncotarget. 2017; 8:15507–15519. DOI: https://doi.org/10.18632/oncotarget.14662

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28616

Publication Alerts

Post-Publication Promotion

Publication Discount

Retraction:

Retraction: In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway